A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 105, 267-273
Abstract
No abstract availableKeywords
Funding Information
- Agence Universitaire de la Francophonie
- Université Libanaise
This publication has 32 references indexed in Scilit:
- Breast cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Biologically active sesquiterpene coumarins fromFerulaspeciesPhytotherapy Research, 2010
- Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivoPhytomedicine, 2010
- Cancer Chemopreventive Activity of Terpenoid Coumarins from Ferula SpeciesPlanta Medica, 2008
- Cancer stem cell: target for anti‐cancer therapyThe FASEB Journal, 2007
- Antiproliferative effects of daucane esters from Ferula communis and F. arrigonii on human colon cancer cell linesPhytotherapy Research, 2005
- Calcium ionophoretic and apoptotic effects of ferutinin in the human Jurkat T-cell lineBiochemical Pharmacology, 2004
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003
- Estrogen and the Risk of Breast CancerNew England Journal of Medicine, 2001
- Mechanistic Aspects of Estrogen Receptor Activation Probed with Constitutively Active Estrogen Receptors: Correlations with DNA and Coregulator Interactions and Receptor Conformational ChangesMolecular Endocrinology, 1997